e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Malignant pleural effusion in 2020: understanding the biology and clinical implications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population
C. Wong (Hong Kong, Hong Kong), W. Wong (Hong Kong, Hong Kong), K. So (Hong Kong, Hong Kong), Y. Yam (Hong Kong, Hong Kong)
Source:
Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Session:
Malignant pleural effusion in 2020: understanding the biology and clinical implications
Session type:
Oral Presentation
Number:
4491
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Wong (Hong Kong, Hong Kong), W. Wong (Hong Kong, Hong Kong), K. So (Hong Kong, Hong Kong), Y. Yam (Hong Kong, Hong Kong). Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population. 4491
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Massive pleural effusion presented with a very rare multitude of complication
Related content which might interest you:
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Malignant pleural effusion survival prognostication in an Asian population
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019
A Dutch web-survey on management of malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Malignant pleural mesothelioma in our material: evaluation by EORTC prognostic scoring system
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001
The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion
Source: Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019
Year: 2020
Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Source: International Congress 2016 – Pleural diseases
Year: 2016
Late Breaking Abstract - Prognostic and therapeutic markers of malignant pleural effusion – The PROMISE study
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017
Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021
Heterogeneous delivery of definitive interventions in malignant pleural effusions – results from a Danish survey.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT)
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018
Malignant pleural effusion: different treatments through countries
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021
Evaluation of patients with pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 247s
Year: 2004
Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021
Risk stratifying pleural infection using RAPID score in an Asian population
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Tool methods in the diagnosis of pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept